ETF Evaluator:
JPMorgan Healthcare Leaders ETF ()
Follow This ETF
(as of Aug 26)
Best Performing in Health Over the Last Year
| 129.4% | Virtus LifeSci Biotech Clinical Trls ETF (BBC) |
| 94.1% | ALPS Medical Breakthroughs ETF (SBIO) |
| 88.4% | F/m Emerald Life Sciences Innovation ETF (LFSC) |
| 72.5% | State Street® SPDR® S&P® Biotech ETF (XBI) |
| 65.8% | State Street® SPDR® S&P® PhrmctlsETF (XPH) |
Risk
Index
Risk
Index
ETF Details
JPMorgan Healthcare Leaders ETF Overview
JPMorgan Healthcare Leaders ETF (JDOC) is an actively managed Sector Equity Health exchange-traded fund (ETF). JPMorgan launched the ETF in 2023.
The investment seeks to provide long-term capital appreciation.
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
About JPMorgan Healthcare Leaders ETF (JDOC)
There are 2 members of the management team with an average tenure of 2.54 years: Dominic Valder (2023) and Bartjan van Hulten (2024). Management tenure is more important for actively managed ETFs than passive index ETFs.
The ETF has 2 primary benchmarks: MSCI World NR USD index with a weighting of 100% and MSCI World/Health Care NR USD index with a weighting of 100%. JPMorgan Healthcare Leaders ETF has 58 securities in its portfolio. The top 10 holdings constitute 48.1% of the ETF’s assets. The ETF meets the SEC requirement of being classified as a diversified fund. The ETF is not considered to have an ESG focus with its investment selection and management.
JPMorgan Healthcare Leaders ETF is part of the Equity global asset class and is within the Sector Equity ETF group. JPMorgan Healthcare Leaders ETF has 20.0% of its portfolio invested in foreign issues. The overall assets allocated to domestic stock is 79.2% There is 20.0% allocated to foreign stock, and 0.0% is allocated to preferred stocks. The bond allocation as a percentage of total assets is 0.0% (0.0% domestic bond, 0.0% foreign bond and 0.0% convertible bond). JPMorgan Healthcare Leaders ETF has 0.8% of the portfolio in cash.
Assets Under Management
The fund has $9 million in total assets, which is below the $1 billion average for the Health category. Normally, lower assets under management translates to higher average expense ratios, and greater total assets are desired. However, for some investment categories, such as small-cap investing, it may be difficult for the manager to fully employ the desired active strategy if assets grow too large or too quickly.
JDOC Performance and Fees
The expense ratio measures how much of a fund’s assets are used for administrative expenses and operating expenses, including adviser fees and fees for the transfer agent and custodial services. The JPMorgan Healthcare Leaders ETF expense ratio is above average compared to funds in the Health category. JPMorgan Healthcare Leaders ETF has an expense ratio of 0.65%, which is 26% higher than its category average, making the fund expense ratio grade a D. While it is difficult to predict returns, it is known that high annual expense ratios reduce your rate of return, and excessive fees are difficult to overcome. Active management normally comes with higher expense ratios than passive index management. Certain investment categories such as small company and foreign also normally have higher expense ratios. It is best to compare fund expense ratios against the category averages for meaningful assessments.
High portfolio turnover can translate to higher expenses and lower aftertax returns. JPMorgan Healthcare Leaders ETF has a portfolio turnover rate of 92%, which indicates that it holds its assets around / 0.0 years. By way of comparison, the average portfolio turnover is 45% for the Health category.
Recently, in the month of July 2026, JPMorgan Healthcare Leaders ETF returned 0.5%, which earned it a grade of C, as the Health category had an average return of -0.1%. The letter grades of A, B, C, D and F are based upon relative rankings within the investment category. A grade of A, for example, would indicate that the return is in the highest 20% for that time period compared to all ETFs in that category.
JPMorgan Healthcare Leaders ETF has a trailing yield of 0.85%, which is below the 1.10% category average.
The fund normally distributes its income none and its capital gains annually.
It’s natural to seek the best-performing investments, but you must consider the relationship between risk and return and the impact of costs and taxes on your realized returns.
JPMorgan Healthcare Leaders ETF Grades
Year to date, the ETF has returned 4.6%, 5.2 percentage points worse than the category, which translates into a grade of D. The fund has returned 24.5% over the past year (grade of D).
For more ETF grades, analysis and screening tools to help your investment discovery, join AAII for a $2, full-access trial. Learn more here: https://invest.aaii.com/membership.
Otherwise, for more information about JPMorgan Healthcare Leaders ETF, including its riskiness, submit your email to unlock the rest of the article.
Gain access to exclusive AAII member-only content.
JDOC Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| JDOC Return (NAV) | 0.5% | 8.8% | 24.5% | na | na | na |
| JDOC Return (Price) | 1.9% | 10.5% | 23.5% | na | na | na |
| NAV +/- Price Return | -1.420% | -1.727% | 1.014% | na | na | na |
| Health Avg | -0.1% | 11.2% | 36.9% | 9.9% | 1.6% | 8.7% |
| JDOC Grade (NAV) | C | D | D | na | na | na |
| +/- Category (NAV) | 0.6% | -2.5% | -12.4% | na | na | na |
| JDOC Tax-Cost Ratio | na | na | 0.4% | na | na | na |
JDOC Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| JDOC Return (NAV) | 4.6% | 14.9% | -0.6% | na | na | na | na | na | na | na | na |
| JDOC Return (Price) | 6.0% | 15.6% | -1.1% | na | na | na | na | na | na | na | na |
| NAV +/- Price Ret | 0.305% | 0.043% | 0.777% | na | na | na | na | na | na | na | na |
| Health Avg | 9.7% | 21.8% | 0.1% | 2.2% | -16.3% | 4.3% | 30.5% | 25.4% | -1.5% | 26.5% | -10.2% |
| JDOC Grade (NAV) | D | D | D | na | na | na | na | na | na | na | na |
| +/- Category | -5.2% | -6.8% | -0.7% | na | na | na | na | na | na | na | na |
| Risk Measures | |
| Beta: | na |
| R-Squared: | na |
| Standard Deviation: | na |
| Category Risk Index: | na |
| Category Risk Rating: | |
| Total Risk Index: | na |
| Total Risk Rating: | |
| Portfolio Characteristics | |
| Yield: | 0.9% |
| Total Assets: | $ 9 Mil |
| Share Class Assets: | $ 9 Mil |
| Turnover: | 92.0% |
| Expense Ratio: | 0.65% |
| Index Fund: | No |
| Index Tracked: | MSCI World NR USD |
| Index Weighting: | 100% |
| Leveraged: | No |
| Socially Responsible Fund: | No |
| Capital Gains Distribution Frequency: | Annually |
| Income Distribution Frequency: | None |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 2.8 years | |||
| Average Tenure: 2.5 years | |||
| Managers (Year): Valder Dominic (2023), van Hulten Bartjan (2024) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 58 |
| % in Top 10 Holdings: | 48.1% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 20.0% |
Portfolio Allocation |
|
| Domestic Stock: | 79.2% |
| Foreign Stock: | 20.0% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 0.8% |
Purchase Information
| Legal Structure: | Open Ended Investment Company |
| Fund Family: | JPMorgan |
| Phone Number: | 844-457-6383 |
| Website: | jpmorganfunds.com |
| Inception Date: | November 1, 2023 |
Expenses and Fees
| Expense Ratio (%): | 0.65% (Rating: Above Avg) |
| Category Average Expense Ratio (%): | 0.52% |
